BMY · NYSE, NYSE · CIK 0000014272

BRISTOL MYERS SQUIBB CO

BRISTOL MYERS SQUIBB CO’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 5, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $48.2B and net income of $7.1B, according to its XBRL data on EDGAR. Its EDGAR record lists 62 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$48.2B
Net income, FY2025
$7.1B
Form 4 filings on record, past 12 months
62

Company overview

Legal name (as filed)
BRISTOL MYERS SQUIBB CO
Tickers
BMY, CELG-RI
SEC Central Index Key (CIK)
0000014272
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
PRINCETON, NJ
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#125 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from BRISTOL MYERS SQUIBB CO’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$46.4BFY2021$46.2BFY2022$45.0BFY2023$48.3BFY2024$48.2BFY2025
Net income
$7.0BFY2021$6.3BFY2022$8.0BFY2023-$8.9BFY2024$7.1BFY2025
BMY annual results
ItemFY2021
ended Dec 31, 2021
FY2022
ended Dec 31, 2022
FY2023
ended Dec 31, 2023
FY2024
ended Dec 31, 2024
FY2025
ended Dec 31, 2025
Revenue$46.4B$46.2B$45.0B$48.3B$48.2B
Net income$7.0B$6.3B$8.0B-$8.9B$7.1B
Diluted EPS$3.12$2.95$3.86-$4.41$3.46
Total assets$109.3B$96.8B$95.2B$92.6B$90.0B
Cash and equivalents$14.0B$9.1B$11.5B$10.3B$10.2B

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

BMY latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 11, 202610-KAnnual report· period Dec 31, 2025Document · Index
Jul 30, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 30, 20268-KResults of operations; Regulation FD disclosure· period Jul 30, 2026Document · Index
Mar 25, 2026DEF 14ADefinitive proxy statement· period May 5, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about BRISTOL MYERS SQUIBB CO, by form type:

4 ×268-K ×311-K ×3144 ×2SCHEDULE 13G ×210-Q ×2S-8 ×1DEFA14A ×1
BMY recent filings
FiledFormWhat it isOriginal
Oct 5, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 2, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026Document · Index
Sep 10, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 9, 2026Document · Index
Sep 9, 2026144Notice of proposed sale of securitiesDocument · Index
Sep 3, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 1, 2026Document · Index
Aug 26, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 25, 2026Document · Index
Aug 25, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 7, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 1, 2026Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 1, 2026Document · Index
Jul 30, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 30, 20268-KResults of operations; Regulation FD disclosure· period Jul 30, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026Document · Index
Jun 16, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 15, 2026Document · Index
Jun 5, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026Document · Index
Jun 5, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Jun 5, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Jun 5, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
May 8, 2026S-8Registration of employee benefit plan securitiesDocument · Index
May 8, 20268-KShareholder vote results· period May 5, 2026Document · Index
May 5, 20264Statement of changes in beneficial ownership (insider trade)· period May 1, 2026Document · Index
Apr 30, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 30, 20268-KResults of operations; Regulation FD disclosure· period Apr 30, 2026Document · Index
Apr 29, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Apr 17, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 1, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index
Apr 2, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 31, 2026Document · Index

Insider filing activity

62 Form 4 filings appear in BRISTOL MYERS SQUIBB CO’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations· Companies headquartered in New Jersey

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000014272 and XBRL company facts. BRISTOL MYERS SQUIBB CO on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.